How to Trip Rapid Review

Step 1: Select articles relevant to your search (remember the system is only optimised for single intervention studies)

Step 2: press

Step 3: review the result, and maybe amend the or if you know better! If we're unsure of the overall sentiment of the trial we will display the conclusion under the article title. We then require you to tell us what the correct sentiment is.

28,320 results for

Topical Corticosteroid

by
...
Latest & greatest
Alerts

Export results

Use check boxes to select individual results below

SmartSearch available

Trip's SmartSearch engine has discovered connected searches & results. Click to show

281. Corticosteroid Associated Osteoporosis

Corticosteroid Associated Osteoporosis Corticosteroid Associated Osteoporosis Toggle navigation Brain Head & Neck Chest Endocrine Abdomen Musculoskeletal Skin Infectious Disease Hematology & Oncology Cohorts Diagnostics Emergency Findings Procedures Prevention & Management Pharmacy Resuscitation Trauma Emergency Procedures Ultrasound Cardiovascular Emergencies Lung Emergencies Infectious Disease Pediatrics Neurologic Emergencies Skin Exposure Miscellaneous Abuse Cancer Administration 4 (...) Corticosteroid Associated Osteoporosis Corticosteroid Associated Osteoporosis Aka: Corticosteroid Associated Osteoporosis , Osteoporosis Secondary to Corticosteroid Use , Steroid-Related Bone Mineral Density Loss , Glucocorticoid Induced Osteoporosis From Related Chapters II. Pathophysiology Bone density decreases the most in the first 3-6 months of oral steroid use III. Risk Factors: Osteoporosis on long-term Corticosteroids More than 10% of those on chronic steroids will have a steroid-induced osteoporotic

2018 FP Notebook

282. Systemic Corticosteroid

corticosteroids , adrenal cortical hormone , adrenal corticosteroid , adrenocorticosteroids , corticoid , corticoids , Adrenal Cortex Hormones , Corticosteroids [respiratory use] (product) , Corticosteroids [skin] (product) , Adrenal cortical hormone , Adrenocorticosteroids , Corticoid preparation (product) , Corticoid preparation , Adrenal cortical hormone (substance) , corticosteroid , Adrenal cortical hormone, NOS , Corticoid preparation, NOS , Corticoid preparation (substance) , Corticosteroids (...) replacement, to suppress the immune system, and to treat some side effects of cancer and its treatment. Corticosteroids are also used to treat certain lymphomas and lymphoid leukemias. Definition (CSP) any of the 21-carbon steroids elaborated by the adrenal cortex (excluding the sex hormones of adrenal origin) in response to adrenocorticotropic hormone (ACTH) released by the pituitary gland or to angiotensin II; called also adrenocorticoid, corticoid, adrenal cortical or adrenocortical steroid

2018 FP Notebook

283. Carpal Tunnel Corticosteroid Injection

Carpal Tunnel Corticosteroid Injection Carpal Tunnel Corticosteroid Injection Toggle navigation Brain Head & Neck Chest Endocrine Abdomen Musculoskeletal Skin Infectious Disease Hematology & Oncology Cohorts Diagnostics Emergency Findings Procedures Prevention & Management Pharmacy Resuscitation Trauma Emergency Procedures Ultrasound Cardiovascular Emergencies Lung Emergencies Infectious Disease Pediatrics Neurologic Emergencies Skin Exposure Miscellaneous Abuse Cancer Administration 4 Carpal (...) Tunnel Corticosteroid Injection Carpal Tunnel Corticosteroid Injection Aka: Carpal Tunnel Corticosteroid Injection , Carpal Tunnel Steroid Injection II. Indications III. Efficacy Short-term Relief in 60-70% cases Long-term (conflicting results) Significant symptom relief beyond one month has not been demonstrated Marshall (2007) Cochrane Database Syst Rev (2):CD001554 Clinical outcome at one year for steroid injection is similar to surgery IV. Precautions Do not inject into Risk of tendon rupture

2018 FP Notebook

284. Epidural Corticosteroid Injection

Epidural Corticosteroid Injection Epidural Corticosteroid Injection Toggle navigation Brain Head & Neck Chest Endocrine Abdomen Musculoskeletal Skin Infectious Disease Hematology & Oncology Cohorts Diagnostics Emergency Findings Procedures Prevention & Management Pharmacy Resuscitation Trauma Emergency Procedures Ultrasound Cardiovascular Emergencies Lung Emergencies Infectious Disease Pediatrics Neurologic Emergencies Skin Exposure Miscellaneous Abuse Cancer Administration 4 Epidural (...) Corticosteroid Injection Epidural Corticosteroid Injection Aka: Epidural Corticosteroid Injection II. Indications with acute radicular pain III. Efficacy Only 6 of 12 controlled trials since 1950 found benefit Study (n=158 ted disc with ) 80 mg in 8 ml of Steroid group had only short-term improvement improved compared with Benefit lasted only 3 months References Images: Related links to external sites (from Bing) These images are a random sampling from a Bing search on the term "Epidural Corticosteroid

2018 FP Notebook

285. Dupuytren's Nodule Corticosteroid Injection

to external sites (from Bing) These images are a random sampling from a Bing search on the term "Dupuytrens Nodule Corticosteroid Injection." Click on the image (or right click) to open the source website in a new browser window. Related Studies (from Trip Database) Related Topics in Procedure About FPnotebook.com is a rapid access, point-of-care medical reference for primary care and emergency clinicians. Started in 1995, this collection now contains 6656 interlinked topic pages divided into a tree of 31 (...) Dupuytren's Nodule Corticosteroid Injection Dupuytrens Nodule Corticosteroid Injection Toggle navigation Brain Head & Neck Chest Endocrine Abdomen Musculoskeletal Skin Infectious Disease Hematology & Oncology Cohorts Diagnostics Emergency Findings Procedures Prevention & Management Pharmacy Resuscitation Trauma Emergency Procedures Ultrasound Cardiovascular Emergencies Lung Emergencies Infectious Disease Pediatrics Neurologic Emergencies Skin Exposure Miscellaneous Abuse Cancer Administration 4

2018 FP Notebook

286. Local Corticosteroid Injection of Plantar Fascia

injection Minimum time to strenuous activity: 48 hours Examine again in 3 weeks post-injection Consider guidance in refractory cases IX. References Greene (2001) Musculoskeletal Care, AAOS, p. 491-2 Images: Related links to external sites (from Bing) These images are a random sampling from a Bing search on the term "Local Corticosteroid Injection of Plantar Fascia." Click on the image (or right click) to open the source website in a new browser window. Related Studies (from Trip Database) Related Topics (...) Local Corticosteroid Injection of Plantar Fascia Local Corticosteroid Injection of Plantar Fascia Toggle navigation Brain Head & Neck Chest Endocrine Abdomen Musculoskeletal Skin Infectious Disease Hematology & Oncology Cohorts Diagnostics Emergency Findings Procedures Prevention & Management Pharmacy Resuscitation Trauma Emergency Procedures Ultrasound Cardiovascular Emergencies Lung Emergencies Infectious Disease Pediatrics Neurologic Emergencies Skin Exposure Miscellaneous Abuse Cancer

2018 FP Notebook

287. Evaluation of Tocilizumab as an add-on Therapy to Corticoids in Horton's Disease: Proof of Concept Study.

: November 8, 2013 Actual Primary Completion Date : December 2015 Actual Study Completion Date : June 13, 2016 Resource links provided by the National Library of Medicine related topics: available for: resources: Arms and Interventions Go to Arm Intervention/treatment Experimental: Prednisone+Tocilizumab Prednisone (0.7 mg/Kg/d and then progressively tapered to reach 0.1 mg/Kg/d at W24) + tocilizumab 8mg/Kg/4 weeks for a total of 4 infusions (S0, S4, S8, S12). Drug: corticoids+ tocilizumab 8mg/Kg/4 weeks (...) Evaluation of Tocilizumab as an add-on Therapy to Corticoids in Horton's Disease: Proof of Concept Study. Evaluation of Tocilizumab as an add-on Therapy to Corticoids in Giant Cell Arteritis: Proof of Concept Study. - Full Text View - ClinicalTrials.gov Hide glossary Glossary Study record managers: refer to the if submitting registration or results information. Search for terms x × Study Record Detail Saved Studies Save this study Warning You have reached the maximum number of saved studies

2013 Clinical Trials

288. Injectable Corticosteroids in Sport. (Abstract)

of the extremities and the axial spine have been described. Numerous minor and major complications have been reported, including those with a high degree of morbidity. There is a dearth of published research on the use of corticosteroid injections in athletes, with most of the research on this topic focused on older, nonathlete populations. Generally, these injections are well tolerated and can provide short-term pain improvement with little or no long-term benefits.Corticosteroid injections should be used (...) Injectable Corticosteroids in Sport. To review the literature guiding all aspects of the use of injectable corticosteroids for painful musculoskeletal conditions, with a focus on the treatment of athletes.An extensive search of the literature was completed including search terms of corticosteroid, steroid, athlete, and injection, among others. Additional articles were used after being identified from previously reviewed articles.Injections of corticosteroids for a variety of painful conditions

2018 Clinical Journal of Sport Medicine

289. Corticosteroids - inhaled

Corticosteroids - inhaled Corticosteroids - inhaled - NICE CKS Share Corticosteroids - inhaled : Summary Corticosteroids are synthetic analogues of hormones produced by the adrenal cortex. Inhaled corticosteroids are glucocorticoids and have 4 main effects, which are: Anti-inflammatory. Immunosuppressive. Anti-proliferative (anti-mitotic). Vasoconstrictive. Inhaled corticosteroids exert these effects on the airways to reduce inflammation, oedema, and mucus secretion. Because they are delivered (...) of the natural hormones that are produced by the adrenal cortex. Like the natural hormones, synthetic corticosteroids can have glucocorticoid and/or mineralocorticoid properties. The glucocorticoid properties are anti-inflammatory, immunosuppressive, anti-proliferative, and vasoconstrictive. The glucocorticoid properties also support a variety of metabolic functions including carbohydrate and protein metabolism, whilst playing a vital role in helping the body adjust to physical stress. The mineralocorticoid

2015 NICE Clinical Knowledge Summaries

290. A comparative study of toluidine blue-mediated photodynamic therapy versus topical corticosteroids in the treatment of erosive-atrophic oral lichen planus: a randomized clinical controlled trial. (Abstract)

A comparative study of toluidine blue-mediated photodynamic therapy versus topical corticosteroids in the treatment of erosive-atrophic oral lichen planus: a randomized clinical controlled trial. Recently, photodynamic therapy (PDT) has been suggested as a new treatment option that is free from side effects for erosive-atrophic oral lichen planus (OLP). The purpose of this study was to compare the effect of toluidine blue-mediated photodynamic therapy (TB-PDT) with local corticosteroids (...) on treatment of erosive-atrophic OLP. In this randomized clinical trial, 25 patients with keratotic-atrophic-erosive oral lichen planus were allocated randomly into two groups. Group 1 (experimental): topical application of toluidine blue with micropipette was applied, and after 10 min, the patients were treated with a 630-nm GaAlAs laser (power density: 10 mW/cm(2)) during two visits. Group 2 (control) used mouthwash diluted with dexamethasone (tab 0/5 in 5 ml water) for 5 min, and then, it was spat out

2014 Lasers in medical science Controlled trial quality: uncertain

291. A Study to Determine Serum and Skin Biopsy Biomarkers in Patients Receiving Topical Corticosteroid (TCS) and Following TCS Withdrawal

A Study to Determine Serum and Skin Biopsy Biomarkers in Patients Receiving Topical Corticosteroid (TCS) and Following TCS Withdrawal A Study to Determine Serum and Skin Biopsy Biomarkers in Patients Receiving Topical Corticosteroid (TCS) and Following TCS Withdrawal - Full Text View - ClinicalTrials.gov Hide glossary Glossary Study record managers: refer to the if submitting registration or results information. Search for terms x × Study Record Detail Saved Studies Save this study Warning You (...) have reached the maximum number of saved studies (100). Please remove one or more studies before adding more. A Study to Determine Serum and Skin Biopsy Biomarkers in Patients Receiving Topical Corticosteroid (TCS) and Following TCS Withdrawal (GNE-AD) The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our for details. ClinicalTrials.gov Identifier

2014 Clinical Trials

292. Topical corticosteroid reduces inflammation without compromising efficacy of photodynamic therapy for actinic keratoses a randomised clinical trial. (Abstract)

Topical corticosteroid reduces inflammation without compromising efficacy of photodynamic therapy for actinic keratoses a randomised clinical trial. Photodynamic therapy (PDT) is an effective and established treatment for actinic keratoses (AK) and nonmelanoma skin cancer. The main side-effects of PDT are post-treatment erythema and oedema, and pain during illumination. Severe erythema after PDT enhances the down time associated with the treatment.To evaluate in a randomized intraindividual (...) study whether use of a topical corticosteroid just before and just after PDT would reduce treatment-induced erythema compared with conventional PDT.Twenty-two patients with multiple AKs in the face and scalp were treated with methyl aminolaevulinate PDT in two symmetrical areas. One area was randomized to superpotent corticosteroid (clobetasol propionate) before and just after PDT. Objective and visual erythema, protoporphyrin IX (PpIX) fluorescence and pain were evaluated.Topical corticosteroid

2014 The British journal of dermatology Controlled trial quality: uncertain

293. Topical Corticosteroids Minimise the Risk of Postinflammatory Hyper-pigmentation After Ablative Fractional CO2 Laser Resurfacing in Asians. Full Text available with Trip Pro

Topical Corticosteroids Minimise the Risk of Postinflammatory Hyper-pigmentation After Ablative Fractional CO2 Laser Resurfacing in Asians. Postinflammatory hyperpigmentation (PIH) is the most common adverse effect of laser treatment in dark-skinned individuals. Little is known whether PIH can be prevented or minimised. The objective of this study was to investigate the effect of short-term application of topical corticosteroids on the incidence of PIH after ablative fractional resurfacing (...) weekly for the first month and at 2 and 3 months post-treatment. The side of the face treated with petrolatum alone had significantly (p < 0.001) higher incidence of PIH (75%) after laser irradiation than the side of the face treated with topical corticosteroids and petrolatum (40%). The PIH occurring on the petrolatum-treated sides had significantly higher intensity (p < 0.001) and was spread over a significantly larger area (p < 0.001), compared with the corticosteroid- and petrolatum-treated sides

2014 Acta Dermato-Venereologica Controlled trial quality: uncertain

294. A randomized controlled clinical trial of topical insulin-like growth factor-1 therapy for sudden deafness refractory to systemic corticosteroid treatment. Full Text available with Trip Pro

A randomized controlled clinical trial of topical insulin-like growth factor-1 therapy for sudden deafness refractory to systemic corticosteroid treatment. To date, no therapeutic option has been established for sudden deafness refractory to systemic corticosteroids. This study aimed to examine the efficacy and safety of topical insulin-like growth factor-1 (IGF-1) therapy in comparison to intratympanic corticosteroid therapy.We randomly assigned patients with sudden deafness refractory (...) to systemic corticosteroids to receive either gelatin hydrogels impregnated with IGF-1 in the middle ear (62 patients) or four intratympanic injections with dexamethasone (Dex; 58 patients). The primary outcome was the proportion of patients showing hearing improvement (10 decibels or greater in pure-tone average hearing thresholds) 8 weeks after treatment. The secondary outcomes included the change in pure-tone average hearing thresholds over time and the incidence of adverse events.In the IGF-1 group

2014 BMC Medicine Controlled trial quality: predicted high

295. Efficacy of honey in comparison to topical corticosteroid for treatment of recurrent minor aphthous ulceration: A randomized, blind, controlled, parallel, double-center clinical trial. (Abstract)

Efficacy of honey in comparison to topical corticosteroid for treatment of recurrent minor aphthous ulceration: A randomized, blind, controlled, parallel, double-center clinical trial. Recurrent aphthous ulceration represents a very common mucosal disorder that general dentists may encounter on a daily basis, and for which there is no curative treatment. The best treatment that can be achieved is to avoid local traumatic precipitants, lessen the pain and duration of ulceration by suppressing (...) period.There were 94 subjects, with 180 minor recurrent aphthous ulcerations. The ulcers were distributed as 67, 57, and 56 ulcers for honey, topical corticosteroid, and Orabase treatment, respectively. There was a statistically significant difference between the honey group and the other two groups in terms of reduction of ulcer size, days of pain, and degree of erythema. No side effects were reported in any group.Honey was found to be effective and safe in reducing minor aphthous ulcer pain, size

2014 Quintessence international (Berlin, Germany : 1985) Controlled trial quality: uncertain

296. Early Addition of Topical Corticosteroids in the Treatment of Bacterial Keratitis. Full Text available with Trip Pro

Early Addition of Topical Corticosteroids in the Treatment of Bacterial Keratitis. Scarring from bacterial keratitis remains a leading cause of visual loss.To determine whether topical corticosteroids are beneficial as an adjunctive therapy for bacterial keratitis if given early in the course of infection.The Steroids for Corneal Ulcers Trial (SCUT) was a randomized, double-masked, placebo-controlled trial that overall found no effect of adding topical corticosteroids to topical moxifloxacin (...) hydrochloride in bacterial keratitis. Here, we assess the timing of administration of corticosteroids in a subgroup analysis of the SCUT. We define earlier administration of corticosteroids (vs placebo) as addition after 2 to 3 days of topical antibiotics and later as addition after 4 or more days of topical antibiotics.We assess the effect of topical corticosteroids (vs placebo) on 3-month best spectacle-corrected visual acuity in patients who received corticosteroids or placebo earlier vs later. Further

2014 JAMA ophthalmology Controlled trial quality: predicted high

297. Fast itch relief in an experimental model for methylprednisolone aceponate topical corticosteroid activity, based on allergic contact eczema to nickel sulphate. (Abstract)

Fast itch relief in an experimental model for methylprednisolone aceponate topical corticosteroid activity, based on allergic contact eczema to nickel sulphate. Topical corticosteroids (TC) consistently show effectiveness against itch, a paradigmatic symptom, in various eczemas. Rapid itch relief is a therapeutic goal. The early response of itch to TC has not been adequately studied.To assess the effect on itch of a TC, methylprednisolone aceponate 0.1% ointment (MPA), in induced eczema

2014 Journal of the European Academy of Dermatology and Venereology Controlled trial quality: uncertain

298. Topical Photodynamic therapy

AK when compared in a randomized clinical trial. 48 Treatment induced erythema was reduced, with further reduction if a superpotent topical corticosteroid is applied just before and after PDT. Another centre has proposed ‘temperature-modulated PDT’ where sustained clearance of 90% of 724 AK at 1 year was achieved by warming the skin during 1 hour Levulan ALA incubation. 49 4. Fluorescent diagnosis The detection of skin surface fluorescence, visible following application of ALA and MAL, can (...) Topical Photodynamic therapy EDF Guidelines Office to Professor Dr. Nast: Martin Dittmann, Klinik für Dermatologie, Venerologie und Allergologie, Campus Charité Mitte, Charité – Universitätsmedizin Berlin, Charitéplatz 1, 10117 Berlin, Germany phone: +49 30 450 618 313, fax: +49 30 450 518 977, e-mail: martin.dittmann@charite.de European Dermatology Forum Guidelines on Topical Photodynamic Therapy Updated version – 2019 Expiry date: 08/2022 European Dermatology Forum Guidelines on Topical

2019 European Dermatology Forum

299. Assessment of the Efficacy of an Intradiscal Injection of Corticoids in Modic I Discopathies.

links provided by the National Library of Medicine related topics: Arms and Interventions Go to Arm Intervention/treatment Active Comparator: Corticoids A group of patients will receive an intradiscal injection of Hydrocortancyl. Drug: Hydrocortancyl. Patients will receive an intradiscal injection of hydrocortancyl. Sham Comparator: Local anaesthetic A group of patients will receive an intradiscal injection of Lidocaine. Drug: Lidocaine Outcome Measures Go to Primary Outcome Measures : Pain (...) Assessment of the Efficacy of an Intradiscal Injection of Corticoids in Modic I Discopathies. Assessment of the Efficacy of an Intradiscal Injection of Corticoids in Modic I Discopathies. - Full Text View - ClinicalTrials.gov Hide glossary Glossary Study record managers: refer to the if submitting registration or results information. Search for terms x × Study Record Detail Saved Studies Save this study Warning You have reached the maximum number of saved studies (100). Please remove one

2012 Clinical Trials

300. A Study to Assess the Efficacy and Safety of Advagraf &#174; Switching From Cyclosporine Between the Group That Was Treated With a 50 % Reduced Corticosteroid and the Group With Maintained Corticosteroid for Stable Kidney Transplant Recipients

That Was Treated With a 50% Reduced Corticosteroid and the Group With Maintained Corticosteroid for Stable Kidney Transplant Recipients Actual Study Start Date : November 21, 2013 Actual Primary Completion Date : November 7, 2015 Actual Study Completion Date : November 7, 2015 Resource links provided by the National Library of Medicine related topics: available for: Arms and Interventions Go to Arm Intervention/treatment Experimental: Corticosteroid with the 50% reduced dose oral Drug: Advagraf oral Drug (...) A Study to Assess the Efficacy and Safety of Advagraf ® Switching From Cyclosporine Between the Group That Was Treated With a 50 % Reduced Corticosteroid and the Group With Maintained Corticosteroid for Stable Kidney Transplant Recipients A Study to Assess the Efficacy and Safety of Advagraf® Switching From Cyclosporine Between the Group That Was Treated With a 50% Reduced Corticosteroid and the Group With Maintained Corticosteroid for Stable Kidney Transplant Recipients - Full Text View

2014 Clinical Trials

To help you find the content you need quickly, you can filter your results via the categories on the right-hand side >>>>